A0 study to assess safety and effectiveness of carbetocin vs oxytocin after delivery of baby in cesarean section to prevent excessive bleeding
Phase 4
- Conditions
- Health Condition 1: O82- Encounter for cesarean delivery without indication
- Registration Number
- CTRI/2024/02/062831
- Lead Sponsor
- siddaganga medical college and research institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
willing to participate
gestational age 36 weeks-41 weeks
patients undergoing cesarean section
Exclusion Criteria
hypertensive
pre eclampsia
eclampsia
ante partum hemorrhage
bleeding disorders
thrombocytopenia
blood coagulation abnormalities
cardiovascular disorders
epilepsy
asthma
migraine
renal disease
liver disease
general anesthesia
retained placenta
placenta accreta
placenta previa
previous pph
grand multipara
fibroid with pregnancy
prolonged labour
hypersensitivity to oxytocin or carbetocin
traumatic pph
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO compare the safety and efficacy of carbetocin with oxytocin to prevent PPH during active management of third stage of labour.Timepoint: blood loss assesment intraoperatively,at 1st hour, 2nd hour post partum, 8th hour, 14th hour, 20th hour, 26th hour.
- Secondary Outcome Measures
Name Time Method To compare adverse effects among both groups.Timepoint: adverse effects noted intraoperatively,at 1st hour, 2nd hour post partum, 8th hour, 14th hour, 20th hour, 26th hour.;To compare the requirement for additional uterotonics in both groupsTimepoint: need for additional uterotonics assesed intraoperatively,at 1st hour, 2nd hour post partum, 8th hour, 14th hour, 20th hour, 26th hour.